Kubota Pharmaceutical Holdings Co., Ltd. Sustainability Profile
Kubota Pharmaceutical Holdings Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia and beyond. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, particularly in the fields of oncology and rare diseases. Kubota Pharmaceutical is renowned for its unique approach to drug development, focusing on precision medicine and advanced biopharmaceuticals. Its core products aim to address unmet medical needs, setting the company apart in a competitive market. With a commitment to research and development, Kubota has achieved significant milestones, including strategic partnerships and successful clinical trials, reinforcing its position as a forward-thinking entity in the pharmaceutical landscape.
DitchCarbon Score
How does Kubota Pharmaceutical Holdings Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kubota Pharmaceutical Holdings Co., Ltd.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kubota Pharmaceutical Holdings Co., Ltd.'s reported carbon emissions
Kubota Pharmaceutical Holdings Co., Ltd., headquartered in Japan, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Kubota Pharmaceutical aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for carbon reduction. In summary, Kubota Pharmaceutical Holdings Co., Ltd. has not yet provided emissions data or climate commitments, indicating a potential area for future development in their sustainability strategy.
How Carbon Intensive is Kubota Pharmaceutical Holdings Co., Ltd.'s Industry?
How Carbon Intensive is Kubota Pharmaceutical Holdings Co., Ltd.'s Location?
Kubota Pharmaceutical Holdings Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kubota Pharmaceutical Holdings Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
